We are building a virtual immune system to improve human health
Discovery Collective was founded in November 2021. We are a multidisciplinary team of computational biologists, immunologists, software engineers, and mathematical biologists. We are building a virtual immune system as a means to represent the complex communication network of the immune system across multiple scaled of biological organization in order to better understand and improve human health.
Co-Founder and Ceo
Dr. Tomas Helikar is the CEO and Co-Founder of Discovery Collective, a state-of-the-art tech company focused on integrating genomic, molecular, cellular, organ, and organismal immune models into a single virtual immune system in order to design better immunological therapies.
Dr. Helikar’s research lab is established within the University of Nebraska, where he’s garnered over $8M in funding to develop his state-of-the-art platform, Cell Collective. Cell Collective supports multi-model, multi-scale, modeling, simulation, visualization, and analysis of large-scale biological processes. Discovery Collective is focused on the identification and validation of new drug targets to treat immune-related diseases.